NCT01085734 Single Site, Masked, Randomized, Controlled Study to Assess Efficacy of Osurdex as Adjunct to Avastin Compared With Avastin Alone in the Treatment of Patients With Macular Edema Due to Central or Branch Retinal Vein Occlusion Status COMPLETED Phase PHASE4
NCT01015300 Bevacizumab (Avastin) in Unresectable/Recurrent Hemangioblastoma From Von-Hippel-Lindau Disease Status TERMINATED Phase EARLY_PHASE1
NCT00979017 Avastin/Temozolomide/Irinotecan for Unresectable/Multifocal Glioblastoma Multiforme Status COMPLETED Phase PHASE2
NCT00945139 Study of Bevacizumab/Doxil in Treatment of Platinum-Resistant/Refractory Ovarian Cancer (CA) Status COMPLETED Phase PHASE2
NCT00745511 Pilot Study to Evaluate the Safety and Efficacy of Treatment With ORA102 Combined With Avastin (Bevacizumab) Versus Avastin Alone, in Patients With Neovascular Age Related Macular Degeneration (AMD) Status UNKNOWN Phase PHASE1/PHASE2
NCT00735306 Phase I/II Trial of Radiation, Avastin and Tarceva for Pancreatic Adenocarcinoma Status COMPLETED Phase PHASE1
NCT00723125 Carboplatin, Abraxane, Avastin as Neoadjuvant Therapy for Her2-Negative Breast Cancer Status COMPLETED Phase PHASE2
NCT00722865 Avastin (Bevacizumab) Plus Adriamycin, Bleomycin, Vinblastine and Dacarbazine (ABVD) for Advanced Stage Hodgkin Lymphoma Status TERMINATED Phase PHASE2
NCT00681876 Phase II Study of Avastin + Erbitux + Irinotecan as 2nd Line Treatment of Colorectal Cancer Status TERMINATED Phase PHASE2
NCT00655850 Lower Dose Chemotherapy Given More Frequent With Avastin to Treat Advanced Non-Squamous Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT00652119 Intraperitoneal Paclitaxel and Carboplatin With IV Avastin Therapy in Patients With Carcinomas of Mullerian Origin Status UNKNOWN Phase PHASE1
NCT00618826 A Study of Biweekly Gemcitabine, Paclitaxel, and Avastin in Patients With Metastatic Breast Cancer Status COMPLETED Phase PHASE2
NCT00611325 Phase II Avastin + Bortezomib for Patients With Recurrent Malignant Glioma Status COMPLETED Phase PHASE2
NCT00609765 Avastin, Fluorouracil, Doxorubicin and Streptozocin in Locally Advanced and Metastatic Pancreatic Endocrine Tumors Status TERMINATED Phase PHASE2
NCT00607113 Avastin (Bevacizumab) and RAD001 (Everolimus) in Advanced Low or Intermediate Grade Neuroendocrine Carcinoma Status COMPLETED Phase PHASE2
NCT00597402 Avastin in Combination With Radiation (XRT) & Temozolomide, Followed by Avastin, Temozolomide and Irinotecan for Glioblastoma (GBM) and Gliosarcomas Status COMPLETED Phase PHASE2